Biotechnology News

February 13, 2013

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will report its 2012 financial results on Thursday, February 21, 2013 at approximately 4:00 p.m. ET. The press release will be followed by a...

February 13, 2013

CONSHOHOCKEN, Pa. & SAN ANTONIO--(BUSINESS WIRE)--As health systems are under increasing pressure to share data across systems to improve and expand their networks of care, CardioNet, Inc. and AirStrip have entered into a partnership...

February 13, 2013

BRIDGEWATER, N.J.--(BUSINESS WIRE)--February 13, 2013--Dendreon Corporation (NASDAQ: DNDN) today announced that results from several ongoing or completed studies investigating the utility of PROVENGE® (sipuleucel-T) in the treatment of advanced...

February 13, 2013

NEW HAVEN, Conn.--(BUSINESS WIRE)--Kolltan Pharmaceuticals appoints Jane Henderson as Senior Vice President and Chief Business Officer.

February 13, 2013

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that food industry leader Dave Pfanzelter has been appointed to the Board of Directors. Mr....

February 13, 2013

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Brian Bollwage will present a live, interactive webinar titled “Coming to America: Regulatory Strategies for Foreign Drug and Device Companies” at 8 a.m. EST on Tuesday, Feb. 26.

February 13, 2013

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (NASDAQ: GTXI) announced today that new data from two Phase II studies on the effects of Capesaris® (GTx-758), a selective estrogen receptor alpha agonist, for the treatment of advanced prostate cancer,...

February 13, 2013

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it has closed its previously announced direct placement to leading healthcare investor, OrbiMed Israel Partners...

February 13, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences, an innovative developer of molecular diagnostic tests, today announced the company will present data on the latest developments related to its CertNDxTM Bladder Cancer Assays at two...

February 13, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today reported consolidated 2012 financial results and reviewed key recent accomplishments. “We continue to make significant progress with tivozanib, including reporting the final...

February 13, 2013

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced its financial results for the fourth quarter and full year ended December 31, 2012. “We are pleased with the performance of AMPYRA in 2012, and excited about...

February 13, 2013

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Retains New IR Group to Optimize Investor Outreach, Relay Key Growth Plans

February 13, 2013

PARIS--(BUSINESS WIRE)--Nanobiotix appoints Dr. Alain Herrera to the Supervisory Board

February 13, 2013

BEERSE, Belgium--(BUSINESS WIRE)--Note: Data in this release correspond to ASCO GU Abstract #5. Janssen Research & Development, LLC [Janssen] announced today long-term results showing ZYTIGA® (abiraterone acetate) plus prednisone continued to...

February 12, 2013

SAN DIEGO & ORLANDO, Fla.--(BUSINESS WIRE)--Epic Sciences is presenting a research poster at the 2013 Genitourinary Cancers Symposium taking place February 14 to 16 from 11:45 am to 1:15 pm EST in Gatlin Ballroom B in Orlando, Fla.

February 12, 2013

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--ForteBio’s new Dip and Read™ Anti-FLAG Biosensor enables researchers to quickly and easily detect FLAG-tagged recombinant proteins for their quantitation and kinetic characterization.

February 12, 2013

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) today announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2012. The Form 20-F is available on Elan's website at...

February 12, 2013

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today reported financial results for the fourth quarter and twelve months ended December 31, 2012. The company also highlighted ADCETRIS (brentuximab vedotin) commercialization...

February 12, 2013

SAN DIEGO--(BUSINESS WIRE)--Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced it will report financial results for its 2012 fourth quarter and full year ended December 31,...

February 12, 2013

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc., a global leader in the manufacture of orthopedic and biotechnology products, announced today that enrollment in the Company’s SternaLock® Blu clinical trial has begun. The SternaLock® Blu clinical...

February 12, 2013

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the fourth quarter and full year ended December 31, 2012. Q4 Product Revenue Up 25%; Full Year Product Revenue Up 27%

February 12, 2013

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering

February 12, 2013

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT Announces First Patient Enrolled in North American Clinical Trial of Mirasol® Pathogen Reduction Technology System

February 12, 2013

SANTA CLARA, Calif. & SALT LAKE CITY--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) and Sera Prognostics Inc., a women’s health company, today announced a strategic partnership to develop proteomic assays for the early prediction of...

February 12, 2013

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX announces company’s first in vitro diagnostic device

February 12, 2013

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today announced that the Company will host a conference call at 10:00 AM EST on Wednesday, February 20, 2013 to review fourth quarter 2012 results. The quarterly results will be...

February 12, 2013

NISKAYUNA, N.Y.--(BUSINESS WIRE)--GE to partner with Vanderbilt Univ. to study how colon cancer tumors form and develop at the cellular level using GE's cancer mapping technology which can analyze up to 60 different disease markers.

February 12, 2013

ATLANTA--(BUSINESS WIRE)--Holzer Fistel Investigate Ventrus

February 12, 2013

MIAMI & LOS ANGELES--(BUSINESS WIRE)--GliSODin Skin Nutrients, an aesthetic product made up of therapeutic-grade nutraceuticals designed to enhance the outcomes of cosmetic procedures and promote skin health and appearance is launching.

February 12, 2013

ANAHEIM, Calif. & CAMBRIDGE, England--(BUSINESS WIRE)--Cambridge Design Partnership is currently exhibiting at MD&M West, the world’s largest medical design and manufacturing event, in Anaheim CA until 16th February. MD&M West is a ‘...

February 12, 2013

SUFFERN, N.Y.--(BUSINESS WIRE)--With the addition of nine patents in 2012, Ryogen LLC now has a portfolio of 23 issued U.S. Patents for genes with significant biomedical research, diagnostic and drug development potential.

February 12, 2013

FORT COLLINS, Colo.--(BUSINESS WIRE)--Ventria Bioscience and researchers at USC have been awarded a Small Business Innovation Research (SBIR) grant to develop a novel alternative to therapeutic insulin for the treatment of diabetes.

February 12, 2013

GARFIELD HEIGHTS, Ohio--(BUSINESS WIRE)--AxioMed® Spine Corporation (www.axiomed.com) announces the commercial introduction of its Freedom® Cervical Disc in Europe with a successful...

February 12, 2013

LISLE, Ill.--(BUSINESS WIRE)--Molex Subsidiary Temp-Flex™ Showcases MediSpec™ Micro Extrusion Primary Wires At MD&M West

February 12, 2013

WOBURN, Mass.--(BUSINESS WIRE)--CryoXtract, a leader in automation solutions for preserving frozen biological samples, announced that the U.S. Patent and Trademark Office issued a Patent Allowance for its aliquotting technology.

February 12, 2013

AUSTIN, Texas--(BUSINESS WIRE)--next generation sequencing data presented by Asuragen Inc.

February 12, 2013

MORRISVILLE, N.C.--(BUSINESS WIRE)--SunTech Medical passes interoperability tests with multiple electronic medical records (EMR) information system providers using IHE’s standards-based profiles at 2013 IHE North American Connectathon.

February 12, 2013

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Bioanalytical Systems named Jacqueline Lemke President & CEO and appointed her to its Board. Continuing as CFO, she was Interim President and CEO since 7/2012, and was named CFO on 4/2012.

February 12, 2013

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the...

February 12, 2013

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics-Intrexon Collaboration Announces Significant Progress Towards Commercial Production of Lead Lantibiotic MU1140

February 12, 2013

NEW YORK--(BUSINESS WIRE)--Retrophin raised $10 million in equity offering.

February 12, 2013

IRVINE, Calif.--(BUSINESS WIRE)--Aviir Inc., a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests, today announced that its current investor group was joined by Partners & Partners...

February 12, 2013

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma was issued patent, number 8370172, which relates to a system and method for electronically submitting medication claims by point-of-care physicians.

February 12, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Firefly BioWorks announces today the Firefly Frontiers Grant. With this grant, Firefly BioWorks will award $10,000 in products and services to support exploratory studies in the area of microRNA.

February 12, 2013

PERKASIE, Pa.--(BUSINESS WIRE)--Secant Medical® has established a new lab to perform polymer synthesis and analytical characterization of polymers, biomaterials and fibers.

February 12, 2013

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today a webcast discussing Capesaris®(GTx-758) and it’s potential role in the treatment of advanced prostate cancer in men is scheduled for Friday, February 15th 2013, from 9:...